Page 20 - Sohini Das

Tata Motors Q2FY25 results: Net profit down 11%, revenue dips 3.5%

The stock fell 1.74 per cent on Friday to Rs 805 per share, as the company missed street estimates, which had projected a net profit of around Rs 5,000 crore

M&M Q2FY25 results: PAT up 35% at Rs 3,171 crore on strong auto sales

Strong auto, farm growth propels automaker's revenue, with record SUV sales

Q2 result preview: 2Ws and 3Ws likely drivers of auto sector growth

Muted PV, CV sales volume in Q2 may reflect in performance of segment leaders

Q2 results preview: Lower input costs may aid pharma firms' margins

Analysts expect overall sales growth to be 10-11%

JCB plans to make machines 'greener' by reducing fossil fuel consumption

Has improved fuel efficiency of machines like backhoe loader by 40% in 10 years

'Ready to export to new electric vehicle markets if there is demand'

Unsoo Kim, president, CEO and MD, Wangdo Hur, executive director and CFO, and Tarun Garg, whole time director and COO of Hyundai Motor India outline their plans

Auto major Hyundai sets ball rolling on India's biggest IPO at Rs 27,856 cr

The firm will be valued at Rs 1.59 trillion at the top-end of the price band of Rs 1,865-Rs 1,960

Amneal Pharma to invest Rs 1,600 crore in Gujarat to make GLP-1 drugs

Globally, there is a shortage of this new class of diabetes and obesity treatment

Glucometer maker Morepen Labs to hive off medical devices business

Expanding capacities, backward integrating production and eyeing US market for exports

Yulu turns Ebitda positive, aims to deploy 100K electric vehicles by 2025

With over 40,000 EVs, Yulu's revenues and users have increased more than sevenfold over the last 24 months

Festival fillip: Car dealerships see four-fold increase in footfall

Dealer sources claimed that even enquiries and bookings are up by 3-4 times when compared to the last 2-3 months

BMW India targets to double electric vehicle penetration by next year

BMW Group India has achieved its best-ever year-to-date car sales, with a 10 per cent growth in the first nine months of calendar year 2024

Taking stock of B'desh: Trade recovers, but Indian firms tread cautiously

The concluding part of the series highlights stabilising trade ties with Dhaka, but payment delays and a complex bilateral environment remain major concerns

Pharmaceutical firms up their game to crackdown on spurious drugs

The concluding part of the series delves into strategies being applied by leading drug firms to battle counterfeits

How safe is the pill? Substandard drugs on a decline amid crackdown

The first of a two-part series focuses on how quality audits and regulatory actions on pharma units nationwide are showing results

Biocon Biologics refinances $1.1 bn debt through bonds, syndicated facility

Refinancing will improve liquidity and help in reinvestment, says company

Dr Reddy's, Hetero sign voluntary licenses with Gilead for HIV drug

Gilead Sciences first launched lenacapavir under the brand name Sunlenca in the United States and European markets in 2022. It is a first-in-class HIV-1 capsid inhibitor

Carmakers expand dealerships to boost sales: Do they have right products?

India's passenger vehicle market is the third largest in the world now, at more than 4 million units a year, but car ownership remains low

From Maruti to Tata, auto firms prune sales to dealers over low demand

September tally hit by Shraddh period, but enquiries and bookings rise

Carlyle-backed SeQuent, Viyash Life Sciences announce Rs 8,000 crore merger

Rs 8,000 crore merger will create one of the largest animal health companies in India